Brief: NextCell Pharma Comments On Potential Merger Between NextCell Pharma And Idogen
26/04/2019 08:21
April 26 (Reuters) - NextCell Pharma Ab NXTCL.TE :
* SAYS DISCUSSIONS ARE CURRENTLY UNDERWAY BETWEEN BOARDS OF
NEXTCELL PHARMA AB AND IDOGEN AB REGARDING A POTENTIAL MERGER
* SAYS BOARD OF DIRECTORS INTENDS TO PUBLISH MORE
INFORMATION SOME
TIME DURING FORTHCOMING WEEK
Source text for Eikon: ID:nWkr4JlRDt
Further company coverage: NXTCL.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln